Search
Selected Filter
Filter Results
Displaying 41–50 of 306 research results for “retinitis pigmentosa”
-
Feb 14, 2013
How an FDA-Approved Retinal Prosthesis Came To Be
The Argus II Retinal Prosthesis System was recently granted market approval by the U.S. Food and Drug Administration (FDA), which marks a significant milestone in the development of a therapy that has spanned more than 20 years.
-
Feb 24, 2022
Second Sight Agrees to Merger to Maintain Retinal and Cortical Prostheses Programs
Company has been unable to meet revenue goals for the Argus II®
-
Feb 7, 2020
Genetic Testing for Inherited Retinal Diseases through the Foundation’s Open Access Program
The benefits of genetic testing for IRD patients, how to participate in the Foundation’s Open Access program, and what to expect from the genetic testing process.
-
Dec 21, 2017
jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment
Some participants reported increased light sensitivity, improved color vision, better mobility, and improved reading ability.
-
Sep 27, 2021
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Current research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
Jul 31, 2018
Forty High-Impact Retinal-Research Efforts Highlighted at FFB-Casey Innovation Summit
In its fifth year, the Innovation Summit featured 40 presentations from industry experts from around the world.
-
Sep 8, 2014
Fascinating Facts About Retinal Cells
The retina is like a multi-layer cake, with each layer comprised of different types of cells, all playing important roles in retinal health and vision.
-
May 10, 2013
Grow Your Own: Harnessing Muller Glia for Retinal Regeneration
There’s hope for retinal regeneration for humans, thanks to Foundation-funded researcher Dr. Thomas Reh, who is investigating how to derive new photoreceptors from retinal cells called Muller glia.
-
Aug 1, 2014
How Evolution is Leading to Gene Therapies for More Retinal Diseases
An innovative genetic-engineering approach called “directed evolution” to find optimal gene-delivery systems based on adeno-associated viruses (AAVs).
-
Apr 16, 2018
Retinal Patch Performs Promisingly in Clinical Trial for Dry AMD Patients
Regenerative Patch Technologies, a company developing stem-cell-derived treatments for people with retinal diseases, has reported encouraging results for the first five patients with advanced, dry age-related macular degeneration (AMD) participating in a Phase I/IIa clinical trial for its therapy – a patch comprised of a layer of retinal pigment epithelial (RPE) cells on a synthetic scaffold.